- Home
- EVI vs CUE Comparison
EVI vs CUE Comparison
Compare EVI & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVI | CUE |
|---|---|---|
| Founded | 1959 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 177.0M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EVI | CUE |
|---|---|---|
| Price | $19.15 | $26.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $88.00 |
| AVG Volume (30 Days) | 48.7K | ★ 385.8K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | N/A | ★ 61.11 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $389,830,000.00 | $27,466,000.00 |
| Revenue This Year | $8.40 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $40.23 | ★ N/A |
| Revenue Growth | 10.26 | ★ 195.75 |
| 52 Week Low | $12.75 | $0.17 |
| 52 Week High | $29.42 | $45.50 |
Technical Indicators
Market Signals| Indicator | EVI | CUE |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | 47.52 |
| Support Level | $18.21 | $24.27 |
| Resistance Level | $19.03 | $33.11 |
| Average True Range (ATR) | 0.94 | 3.09 |
| MACD | -0.18 | -0.32 |
| Stochastic Oscillator | 16.61 | 34.19 |
Price Performance
Historical ComparisonAbout EVI EVI Industries Inc.
EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.